Nonmelanoma skin cancer and melanoma in HIV-1-infected patients.

AIDS
Alessandra LatiniMauro Zaccarelli

Abstract

: In the cART era, the incidence of AIDS-defining cancers decreased, whereas a persistence of non-AIDS-defining cancers has been observed. In particular, concerning the risk of melanoma and nonmelanoma skin cancers in HIV patients, conflicting data are available. In this study, our aim was to assess the occurrence of cutaneous malignancies in 97 HIV-positive individuals visited in our Institute, and to evaluate the association with immunological parameters, as well as combination antiretroviral therapy (cART) duration.

References

Jan 8, 2013·Journal of the National Cancer Institute·Michael J SilverbergMaryam M Asgari
May 23, 2015·International Journal of STD & AIDS·Honglei ZhaoSongting Wang
Mar 17, 2016·JAMA Dermatology·Silvia Soohyun SongShang I Brian Jiang
Mar 29, 2018·Journal of the American Academy of Dermatology·Silje Haukali OmlandLars Haukali Omland
Dec 27, 2018·The Journal of the Association of Nurses in AIDS Care : JANAC·Howa YeungSuephy C Chen

❮ Previous
Next ❯

Citations

Jan 1, 2021·Case Reports in Ophthalmological Medicine·Stephanie M TillitJohn T LiVecchi

❮ Previous
Next ❯

Related Concepts

Related Feeds

AIDS Malignancies (ASM)

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.

Related Papers

Gan to kagaku ryoho. Cancer & chemotherapy
Minoru Saida
Gan to kagaku ryoho. Cancer & chemotherapy
Toshiaki Saida
Gan to kagaku ryoho. Cancer & chemotherapy
Toshiaki Saida
Gan to kagaku ryoho. Cancer & chemotherapy
Toshiaki Saida
Gan to kagaku ryoho. Cancer & chemotherapy
Toshiaki Saida
© 2021 Meta ULC. All rights reserved